Researchers at Harvard University and the Wyss Institute are developing an injectable biomaterial that forms a tiny scaffold in the body which can be used to re-program cells and trigger an immune response to fight cancer and infectious diseases. Ben Gruber Reports.
Video provided by Reuters
www.geg-tech.com